Adipose-derived stem cells for wound healing applications

Annals of Plastic Surgery

Volumn 66, Issue 2, 2011, Pages 210-215

  Cherubino, Mario ^a   Rubin, J Peter ^a,b,c   Miljkovic, Natasa ^a   Kelmendi Doko, Arta ^a   Marra, Kacey G ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

Adipose derived stem cells; soft tissue repair; wound healing

Indexed keywords

ADIPOSE TISSUE; ANIMAL; CHRONIC DISEASE; CYTOLOGY; HUMAN; INJURY; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; WOUND HEALING;

ADIPOSE TISSUE; ANIMALS; CHRONIC DISEASE; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 78751704177     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3181e6d06c     Document Type: Review

References (126)

1. Menke N, Ward K, Witten T, et al. Impaired wound healing. Clin Dermatol. 2007;25:19-25.
2. Lazarus G, Cooper D, Knighton D, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994;2:165-170.
3. Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev. 2001;17:246-249.
4. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30:145-151.
5. Simka M, Majewski E. The social and economic burden of venous leg ulcers: focus on the role of micronized purified flavonoid fraction adjuvant therapy. Am JClin Dermatol. 2003;4:573-581.
6. Mustoe TA. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004;187:65.
7. Olin J, Beusterien K, Childs M, et al. Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study. Vasc Med. 1999;4:1-7.
8. Robson M, Phillips T, Falanga V, et al. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 2001;9:347-352.
9. Mustoe T, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006;117(suppl 7):S35-S41.
10. Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;26: 2648-2659.
11. Singer A, Clark R Cutaneous wound healing. N Engl J Med. 1999;341: 738-746.
12. Harding K, Morris H, Patel G. Science, medicine and the future: healing chronic wounds. BMJ. 2002;324:160-163.
13. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219-1222.
14. Hanjaya-Putra D, Gerecht S. Vascular engineering using human embryonic stem cells. Biotechnol Prog. 2009;25:2-9.
15. Sorrell J, Baber M, Caplan A. Influence ofadultmesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A. 2009;15:1751-1761.
16. Wu Q, Shao H, Darwin ED, et al. Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy. J Cell Mol Med. 2009;13:3764-3773.
17. Watkins S, Zippin J. When wound healing goes awry. A review ofnormal and abnormal wound healing, scar pathophysiology, and therapeutics. JDrugs Dermatol. 2008;7:997-1005.
18. Medina A, Scott P, Ghahary A, et al. Pathophysiology of chronic nonhealing wounds. JBurn Care Rehabil. 2006;26:306-319.
19. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7:201-207.
20. Heit J, Rooke T, Silverstein M, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg. 2001;33:1022-1007.
21. Rogers A, Burnett S, Moore J, et al. Involvement of proteolytic enzymes\plasminogen activators and matrix metalloproteinases\in the pathophysi-ology of pressure ulcers. Wound Repair Regen. 1995;3:273-283.
22. Boulton AJ. The diabetic foot: a global view. Diabetes Metab Res Rev. 2000;16(suppl 1):S2-S5.
23. Jeffcoate W, Price P, Harding K. Wound healing and treatments for people with diabetic footulcers. Diabetes Metab Res Rev. 2004;20(suppl 1):S78-S89.
24. Wu L, Xia Y, Roth S, et al. Transforming growth factor-beta1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. Am J Pathol. 1999; 154:309-309.
25. Rosenberg DS, Lu L, Gurjala A, et al. Aged rats display increased ischemia perfusion skin injury in the in vivo magnet model. Wound Repair Regen. 2004;12:A12.
26. Robson M. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997;77:637-650.
27. Bowler P. Wound pathophysiology, infection and therapeutic options. Ann Med. 2002;34:419-427.
28. Trengove N, Stacey M, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7:442-452.
29. Han Y, Tuan T, Hughes M, et al. Transforming growth factor-beta-and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. JBiol Chem. 2001;276:22341-22350.
30. Hakkinen L, Koivisto L, Gardner H, et al. Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds. Am J Pathol. 2004;164:229-242.
31. Devalaraja R, Nanney L, Du J, et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 2000;115:234-244.
32. Keane M, Belperio J, Arenberg D, et al. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angio-genesis. J Immunol. 1999;163:5686-5692.
33. Xia Y, Zhao Y, Tyrone J, et al. Differential activation of migration by hypoxia in keratinocytes isolated from donors of increasing age: implication for chronic wounds in the elderly. J Invest Dermatol. 2001;116:50-56.
34. Bennett N, Schultz G. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am JSurg. 1993;166:74-81. (Pubitemid 23281429)
35. Shukla A, Dubey M, Srivastava R, et al. Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Commun. 1998;244:434-439.
36. Fu X, Shen Z, Guo Z, et al. Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor. Chin Med J (Engl). 2002;115: 331-335.
37. Cha J, Falanga V. Stem cells in cutaneous wound healing. Clin Dermatol. 2007;25:73-78.
38. Fonder M, Lazarus G, Cowan D, et al. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. JAm Acad Dermatol. 2008;58:185-206.
39. Argenta L, Morykwas M. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38: 563-576.
40. Hansen S, Voigt D, Wiebelhaus P, et al. Using skin replacement products to treat burns and wounds. Adv Skin Wound Care. 2001;14:37-44.
41. Berendt AR. Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis. 2006;43:193-198.
42. Tom W, Peng D, Allaei A, et al. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. Arch Dermatol. 2005;141: 1373-1377.
43. Jull A, Waters J, Arroll B. Pentoxifylline for treating venous leg ulcers. Cochrane Database Syst Rev. 2007:CD001733.
44. Smiell JM, Wieman TJ, Steed DL, et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 1998;7:335-334.
45. Marston WA, Hanft J, Norwood P, et al. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26:1701-1705.
46. Brem H, Balledux J, Bloom T, et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch Surg. 2000;135:627-634.
47. Branski L, Gauglitz G, Herndon D, et al. A review of gene and stem cell therapy in cutaneous wound healing. Burns. 2009;35:171-178.
48. Lynch S, Nixon J, Colvin R, et al. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA. 1987;84:7696-7700.
49. Sprugel K, McPherson J, Clowes AW, et al. Effects of growth factors in vivo: Part I. cell in growth into porous subcutaneous chambers. Am JPathol. 1987;129:601-613.
50. Jeschke M, Klein D. Liposomal gene transfer of multiple genes is more effective than gene transfer of a single gene. Gene Ther. 2004;11:847-855.
51. Robson MC, Mustoe TA, Hunt TK The future of recombinant growth factors in wound healing. Am JSurg. 1998;176(suppl 2A):80S-82S.
52. Cross K, Mustoe T. Growth factors in wound healing. Surg Clin North Am. 2003;83:531-545.
53. Weissman I, Anderson D, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Ann Rev Cell DevBiol. 2001;17:387-403.
54. Kokai LE, Rubin JP, Marra KG. The potential of adipose-derived adult stem cells as a source of neuronal progenitor cells. Plast Reconstr Surg. 2005; 116:1453-1460.
55. Till J, McCulloch E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:1419-1430.
56. Martin G. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA. 1981;78:7634-7638.
57. Hadjantonakis A, Papaioannou V. The stem cells of early embryos. Differ-entiation. 2001;68:159-166.
58. Murray P, Edgar D. The topographical regulation of embryonic stem cell differentiation. Philos Trans R Soc LondB Biol Sci. 2004;359:1009-1020.
59. Charruyer A, Ghadially R. Stem cells and tissue-engineered skin. Skin Pharmacol Physiol. 2009;22:55-62.
60. Murasawa S, Asahara T. Cardiogenic potential of endothelial progenitor cells. Ther Adv Cardiovasc Dis. 2008;2:341-348.
61. Porada C, Zanjani E, Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther. 2006;1:365-369.
62. Niesler C, Schabort E, Myburgh K, et al. Potential myogenic stem cell populations: sources, plasticity and application for cardiac repair. Stem Cells Dev. 2009;18:813-830.
63. Gallicano G, Golestaneh N, Kokkinaki M, et al. Pluripotent stem cells derived from adult human testes. Stem Cells Dev. 2009;18:1115-1126.
64. Wu Y, Wang J, Scott P, et al. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007;15(suppl 1):S18-S26.
65. Fu X, Li H. Mesenchymal stem cells and skin wound repair and regenera-tion: possibilities and questions. Cell Tissue Res. 2009;335:317-321.
66. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004;22: 812-822.
67. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. JLeukoc Biol. 2001;69:513-521.
68. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentia-tion. Arthritis Res. Ther. 2007;9:204.
69. Ishii G, Sangai T, Sugiyama K, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells. 2005; 23:699-706. (Pubitemid 40647266)
70. Deng W, Han Q, Liao L, et al. Engrafted bone marrow-derived flk-(1 +) mesenchymal stem cells regenerate skin tissue. Tissue Eng. 2005;11:110-109.
71. Mori L, Bellini A, Stacey M, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res. 2005;304:81-90.
72. Krause D, Theise N, Collector M, et al. Multi-organ, multi-lineage engraft-ment by a single bone marrow-derived stem cell. Cell. 2001;105:369-377.
73. Jiang Y, Jahagirdar B, Reinhardt R, et al. Pluripotency ofmesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
74. Liang L, Bickenbach J. Somatic epidermal stem cells can produce multiple cell lineages during development. Stem Cells. 2002;20:21-31.
75. Peacock E. Wound Repair. Philadelphia, PA: WB Saunders; 1984.
76. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004;22: 812-822.
77. Rasulov M, Vasilchenkov A, Onishchenko N, et al. First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med. 2005;139:141-144.
78. Hao L, Wang J, Zou Z, et al. Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury. Gene Ther. 2009;16:34-42.
79. Simman R, Craft C, McKinney B. Improved survival of ischemic random skin flaps through the use of bone marrow nonhematopoietic stem cells and angiogenic growth factors. Ann Plast Surg. 2005;54:546-552.
80. Wilgus TA, Ferreira AM, Oberyszyn TM, et al. Regulation of scar formation by vascular endothelial growth factor. Lab Invest. 2008;88:579-590.
81. Falanga V, Iwamoto S, Chartier M, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13: 1299-1312.
82. Rao M, Mattson M. Stem cells and aging: expanding the possibilities. Mech Ageing Dev. 2001;122:713-734.
83. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-4295.
84. Cowan C, Shi Y, Aalami O, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol. 2004;22:560-567.
85. Wei Y, Hu Y, Lv R, et al. Regulation of adipose-derived adult stem cells differentiating into chondrocytes with the use of rhBMP-2. Cytotherapy. 2006;8:570-579.
86. Rubin JP, Bennett JM, Doctor JS, et al. Collagenous microbeads as a scaffold for tissue engineering with adipose-derived stem cells. Plast Reconstr Surg. 2007;120:414-424.
87. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio JMed. 2005;54:132-141.
88. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-222.
89. Patrick CW. Breast tissue engineering. Ann Rev Biomed Eng. 2004;6:109-130.
90. Patrick CW, Mikos AG, McIntire LV. Frontiers in Tissue Engineering. 1st ed. Oxford, United Kingdom and New York, NY: Pergamon; 1998.
91. Chen L, Tredget EE, Liu C, et al. Analysis of allogenicity ofmesenchymal stem cells in engraftment and wound healing in mice. PLoS One. 2009;4: e7119.
92. Stoff A, Rivera AA, Banerjee NS, et al. Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol. 2009;18:362-369.
93. Nelson TJ, Behfar A, Yamada S, et al. Stem cell platforms for regenerative medicine. Clin Transl Sci. 2009;2:222-227.
94. D'Ippolito G, Schiller PC, Ricordi C, et al. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. JBone Miner Res. 1990;14:1115-1122.
95. Huibregtse B, Johnstone B, Goldberg V, et al. Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrow-derived mesen-chymal progenitor cells. J Orthop Res. 2000;18:18-24.
96. Oreffo RO, Bord S, Triffitt JT. Skeletal progenitor cells and ageing human populations. Clin Sci (Lond). 1998;94:549-555.
97. Schipper BM, Marra KG, Zhang W, et al. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg. 2008;60:538-544.
98. Casteilla L, Planat-Bénard V, Cousin B, et al. Plasticity of adipose tissue: a promising therapeutic avenue in the treatment of cardiovascular and blood diseases? Arch Mal Coeur Vaiss. 2005;98:922-926.
99. Planat-Bénard V, Menard C, André M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004;94:223-229.
100. Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascu-larization in vivo. Biochem Biophys Res Commun. 2005;332:370-379.
101. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292-1298.
102. Traktuev D, Merfeld-Clauss S, Li J, et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal sur-face markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res. 2008;102:77-85.
103. Kim WS, Park BS, Sung JH, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48:15-24.
104. Lu F, Mizuno H, Uysal C, et al. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg. 2008;121:50-58.
105. Moon M, Kim S, Kim Y, et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem. 2006;17:279-290.
106. Song Y, Gehmert S, Sadat S, et al. VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Commun. 2007;354:999-1003.
107. Cherubino M, Marra K. Adipose-derived stem cells for soft tissue recon-struction. Regen Med. 2009;4:109-117.
108. Ebrahimian T, Pouzoulet F, Squiban C, et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol. 2009;29:503-510.
109. Aaronson S, Bottaro D, Miki T, et al. Keratinocyte growth factor: a fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci. 1991;638:62-77.
110. Miki T, Bottaro D, Fleming T, et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA. 1992;89:246-250.
111. Jeschke M, Herndon D. The combination of IGF-I and KGF cDNA im-proves dermal and epidermal regeneration by increased VEGF expression and neovascularization. Gene Ther. 2007;14:1235-1242.
112. Nie C, Yang D, Morris SF. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. Med Hypotheses. 2009;72:679-382.
113. Rossiter H, Barresi C, Pammer J, et al. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res. 2004;64:3508-3516.
114. Deodato B, Arsic N, Zentilin L, et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther. 2002;9:777-785.
115. Trottier V, Marceau-Fortier G, Germain L, et al. IFATS collection: using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells. 2008;26:2713-2723.
116. Pouliot R, Larouche D, Auger F, et al. Reconstructed human skin produced in vitro and grafted on athymic mice. Transplantation. 2002;73:1751-1757.
117. Vermette M, Trottier V, Ménard V, et al. Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells. Biomaterials. 2007;28:2850-2860.
118. Nie C, Yang D, Morris S. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. Med Hypotheses. 2009;72:679-682.
119. Beniker D, McQuillan D, Livesey S, et al. The use of acellular dermal matrix as a scaffold for periosteum replacement. Orthopedics. 2003;26(suppl 5): S591-S596.
120. Altman A, Matthias N, Yan Y, et al. Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials. 2008;29:1431-1442.
121. Nambu M, Kishimoto S, Nakamura S, et al. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Ann Plast Surg. 2009;62:317-321.
122. Tsuboi R, Rifkin D. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med. 1990;172:245-251.
123. Blanton M, Hadad I, Johnstone B, et al. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg. 2009;123(suppl 2):56S-64S.
124. Kakudo N, Minakata T, Mitsui T, et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008;122:1352-1360.
125. Kim WS, Park BS, Sung JH. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther. 2009;9:879-887.
126. Rigotti G, Marchi A, Galiè M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. PlastReconstr Surg. 2007;119:1409-1422; discussion 1423-1404.